These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18220599)

  • 1. Evidence for the involvement of resistin in inflammation and cardiovascular disease.
    Gómez-Ambrosi J; Frühbeck G
    Curr Diabetes Rev; 2005 Aug; 1(3):227-34. PubMed ID: 18220599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adiposity as a determinant of an inflammatory milieu.
    Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome.
    Abate N; Sallam HS; Rizzo M; Nikolic D; Obradovic M; Bjelogrlic P; Isenovic ER
    Curr Pharm Des; 2014; 20(31):4961-9. PubMed ID: 24320036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking resistin, inflammation, and cardiometabolic diseases.
    Park HK; Kwak MK; Kim HJ; Ahima RS
    Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin: insulin resistance to malignancy.
    Codoñer-Franch P; Alonso-Iglesias E
    Clin Chim Acta; 2015 Jan; 438():46-54. PubMed ID: 25128719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines: the missing link between insulin resistance and obesity.
    Antuna-Puente B; Feve B; Fellahi S; Bastard JP
    Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.
    Devanoorkar A; Kathariya R; Guttiganur N; Gopalakrishnan D; Bagchi P
    Dis Markers; 2014; 2014():930206. PubMed ID: 24692844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines as uremic toxins.
    Teta D
    J Ren Nutr; 2012 Jan; 22(1):81-5. PubMed ID: 22200420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adipokines in complications related to obesity: a review.
    Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
    Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue and its relation to inflammation: the role of adipokines.
    Axelsson J; Heimbürger O; Lindholm B; Stenvinkel P
    J Ren Nutr; 2005 Jan; 15(1):131-6. PubMed ID: 15648022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines.
    Emamalipour M; Seidi K; Jahanban-Esfahlan A; Jahanban-Esfahlan R
    J Cell Physiol; 2019 Dec; 234(12):21758-21769. PubMed ID: 31187484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflamed adipose tissue, insulin resistance and vascular injury.
    Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U
    Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adipokine update - new molecules, new functions].
    Gelsinger C; Tschoner A; Kaser S; Ebenbichler CF
    Wien Med Wochenschr; 2010 Aug; 160(15-16):377-90. PubMed ID: 20812049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
    Zaidi SI; Shirwany TA
    J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
    Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
    Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study.
    Yang W; Li Y; Wang JY; Han R; Wang L
    Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.